Modulation of Aromatase by Phytoestrogens
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The aromatase enzyme catalyzes the conversion of androgens to estrogens in many human tissues. Estrogens are known to stimulate cellular proliferation associated with certain cancers and protect against adverse symptoms during the peri- and postmenopausal intervals. Phytoestrogens are a group of plant derived naturally occurring compounds that have chemical structures similar to estrogen. Since phytoestrogens are known to be constituents of animal/human food sources, these compounds have received increased research attention. Phytoestrogens may contribute to decreased cancer risk by the inhibition of aromatase enzyme activity and CYP19 gene expression in human tissues. This review covers (a) the aromatase enzyme (historical descriptions on function, activity, and gene characteristics), (b) phytoestrogens in their classifications and applications to human health, and (c) a chronological coverage of aromatase activity modulated by phytoestrogens from the early 1980s to 2015. In general, phytoestrogens act as aromatase inhibitors by (a) decreasing aromatase gene expression, (b) inhibiting the aromatase enzyme itself, or (c) in some cases acting at both levels of regulation. The findings presented herein are consistent with estrogen’s impact on health and phytoestrogen’s potential as anticancer treatments, but well-controlled, large-scale studies are warranted to determine the effectiveness of phytoestrogens on breast cancer and age-related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies
Manach, C., Williamson, G., Morand, C., Scalbert, A., & Rémésy, C. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.230s · Cited by 4,219 · cited 4×
“Additionally, phytoestrogens denote a wide variety of compounds, which are divided into several classes, that is, hydroxybenzoic acids, hydroxycinnamic acids, anthocyanins, proanthocyanidins, flavonols, flavones, flavanols, flavanones, isoflavones, stilbenes, and lignans [25].”
BackgroundInfluentialSource of Estrogen Production in Postmenopausal Women1
GRODIN, J. M., SIITERI, P. K., & MACDONALD, P. C. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-36-2-207 · Cited by 959
Simpson, E. R., Clyne, C., Rubin, G., Boon, W. C., Robertson, K., Britt, K., Speed, C., & Jones, M. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081601.142703 · Cited by 773
Concentration of the Phytoalexin Resveratrol in Wine
Siemann, E. H., & Creasy, L. L. (1992) · American Journal of Enology and Viticulture · doi:10.5344/ajev.1992.43.1.49 · Cited by 719
Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease
Setchell, K. D., Borriello, S. P., Hulme, P., Kirk, D. N., & Axelson, M. (1984) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/40.3.569 · Cited by 619
Structural basis for androgen specificity and oestrogen synthesis in human aromatase
Ghosh, D., Griswold, J., Erman, M., & Pangborn, W. (2009) · Nature · doi:10.1038/nature07614 · Cited by 618 · cited 1×
“Moreover, the aromatase crystal structure was not reported until 2009 [18].”
BackgroundEquol: History, Chemistry, and Formation
Setchell, K. D. R., & Clerici, C. (2010) · The Journal of Nutrition · doi:10.3945/jn.109.119776 · Cited by 519 · cited 6×
“Equol was first isolated in 1932 and then identified approximately 50 years later in human urine as metabolite of the soy isoflavone daidzein [48].”
BackgroundInfluentialA review of brain aromatase cytochrome P450
LEPHART, E. (1996) · Brain Research Reviews · doi:10.1016/0165-0173(96)00002-1 · Cited by 505 · cited 3×
“Notably, the C-19 sex steroids, androstenedione and testosterone, have unsaturated A-ring structures that can serve as substrates in the aromatase reaction [17, 19, 20].”
BackgroundSelf-citationResveratrol supplementation improves glycemic control in type 2 diabetes mellitus
Bhatt, J. K., Thomas, S., & Nanjan, M. J. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.06.003 · Cited by 475 · cited 1×
“For example, resveratrol treatment not only covered cardiovascular protective actions but also alleviated diabetesinduced cardiovascular disorders via different endogenous signaling pathways including oxidative stress and glucose and insulin metabolism [44] as well as antidiabetic actions [45, 46].”
BackgroundThe pharmacology of resveratrol in animals and humans
Park, E.-J., & Pezzuto, J. M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.01.014 · Cited by 302
Pilot study of resveratrol in older adults with impaired glucose tolerance
Crandall, J. P., Oram, V., Trandafirescu, G., Reid, M., Kishore, P., Hawkins, M., Cohen, H. W., & Barzilai, N. (2012) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glr235 · Cited by 281
Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans
Kamat, A., Hinshelwood, M. M., Murry, B. A., & Mendelson, C. R. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(02)00567-2 · Cited by 215
Kang, X., Zhang, Q., Wang, S., Huang, X., & Jin, S. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.091298 · Cited by 141
Post-diagnosis soy food intake and breast cancer survival: A meta-analysis of cohort studies
Chi, F., Wu, R., Zeng, Y.-C., Xing, R., Liu, Y., & Xu, Z.-G. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.4.2407 · Cited by 108
Gopaul, R., Knaggs, H. E., & Lephart, E. D. (2012) · BioFactors · doi:10.1002/biof.191 · Cited by 72 · cited 1×
“Equol is also a superior antioxidant, having greater antioxidant capacity than vitamin C or vitamin E [49], and it has many other benefits covering cosmetics, prostate, and breast cancer along with several other health applications [48–52].”
BackgroundSelf-citationLephart, E. D. (2013) · Pharmaceutical Biology · doi:10.3109/13880209.2013.793720 · Cited by 37 · cited 1×
“Equol is also a superior antioxidant, having greater antioxidant capacity than vitamin C or vitamin E [49], and it has many other benefits covering cosmetics, prostate, and breast cancer along with several other health applications [48–52].”
BackgroundSelf-citation
Cited by
Skin aging and oxidative stress: Equol’s anti-aging effects via biochemical and molecular mechanisms
Lephart, E. D. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.08.001 · Cited by 325
“10A) (Lephart, 2013b; Lephart, 2015; Setchell and Clerici, 2010).”
Self-citationWu, S., & Tian, L. (2017) · Molecules · doi:10.3390/molecules22101606 · Cited by 235
Lephart, E. D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061193 · Cited by 50
“In higher plants, thousands of molecules have polyphenolic structures that are thought to be involved in protecting plants against ultraviolet radiation, aggression by pathogens or stress-related responses such as drought or other extreme environmental conditions [26–29]; see [26] for a review of polyphenolic compound…”
BackgroundSelf-citation
Metadata
- Authors
- Lephart, E. D.
- Venue
- Enzyme Research
- Publisher
- Wiley
- Published
- 2015-12-21
- Volume
- 2015
- Pages
- 1-11
- ISSN
- 2090-0406 (ISSN-L)
- 2090-0414
- OpenAlex
- W2206972683
- Cited by
- 81
- References
- 16
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.